Compound Detail

CHEMBL4864663

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4C[C@@H]5O[C@H](CC[C@@H](C)COC(=O)[C@@H](N)Cc6ccccc6)[C@@H](C)[C@@H]5[C@@]4(C)CC[C@@H]32)C1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4864663
Phase	Preclinical
Structure Type	MOL
InChI Key	XBIOZUSSMLQGJZ-PNJOMUIPSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

605.9

MW (Da)

7.04

ALogP

HBA

HBD

87.8

PSA (Å²)

0.24

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 4 meas. best 5.08

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
T-24 CHEMBL614774	IC50	5.08	5.08	8220.0	1
K562 CHEMBL385	IC50	4.8	4.8	15770.0	1
HepG2 CHEMBL395	IC50	4.73	4.73	18750.0	1
A549 CHEMBL392	IC50	4.57	4.57	27220.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
T-24	IC50	=	8220.0	nM	5.08	Cytotoxicity against human T24 cells assessed as inhibition of cell growth incub...	33740546
K562	IC50	=	15770.0	nM	4.8	Cytotoxicity against human K562 cells assessed as inhibition of cell growth incu...	33740546
HepG2	IC50	=	18750.0	nM	4.73	Cytotoxicity against human HepG2 cells assessed as inhibition of cell growth inc...	33740546
A549	IC50	=	27220.0	nM	4.57	Cytotoxicity against human A549 cells assessed as inhibition of cell growth incu...	33740546

PubMed	DOI	Target Context	# Activities
33740546	10.1016/j.ejmech.2021.113361	K562	1
33740546	10.1016/j.ejmech.2021.113361	T-24	1
33740546	10.1016/j.ejmech.2021.113361	MKN-45	1
33740546	10.1016/j.ejmech.2021.113361	HepG2	1
33740546	10.1016/j.ejmech.2021.113361	A549	1
33740546	10.1016/j.ejmech.2021.113361	MCF7	1

Data from ChEMBL 36 via Core Engine